Arkolith/Insider Trading/TRIL/Form 4

Petrova Penka

Chief Development OfficerTrillium Therapeutics Inc. (TRIL) · full profile →Form 4 · filed Apr 9, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$59K
Net Open-Market Flow
-$59K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2021Option exercise(M)3K$0.30$8123K
Apr 8, 2021Option exercise(M)3K$3.36$9K5K
Apr 8, 2021Sell(S)5K$11.09$59K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 8, 2021Option exercise(M)3K—$049K
Apr 8, 2021Option exercise(M)3K—$084K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-21-003541) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML